Latest news with #Nuix
Mint
6 days ago
- Business
- Mint
Tech Mahindra Q1: Profit jumps, revenue stalls. What's next for investors?
Tech Mahindra is a leading Indian multinational information technology services and consulting company. It is part of the Mahindra Group. The company operates worldwide, with a presence in over 90 countries and 148,517 employees. It serves clients in various sectors including banking, telecommunications, healthcare, manufacturing, retail, media and public services. In recent years, Tech Mahindra has expanded through strategic acquisitions and enhanced its focus on emerging technologies such as artificial intelligence, internet of things, and blockchain. Tech Mahindra announced its results for the first quarter of FY26 after hours on 16 July. The stock was down slightly the next day. Revenue flat, profit surges Tech Mahindra reported Q1 2026 revenue that was slightly behind estimates, beat on net profit. Let's take a look at what the company achieved in dollar terms. Revenue came in at $1.56 billion, up about 0.4% year-on-year. Earnings before interest and taxes (Ebit) increased 30.2% year-on-year to $172 million. Net profit kept pace with Ebita, also increasing 30.2% year-on-year to $133 million. Free cash flow came in at $86 million. Tech Mahindra's total expenditure fell during the quarter, boosting the bottom line. Revenue from the Americas, which account for the bulk of revenues, fell 5.9% compared to last year. The manufacturing and healthcare & lifesciences verticals shrunk, while BFSI, retail, and logistics & transport grew. New deal wins surged to $809 million from $534 million in the same quarter last year. What did management say? Mohit Joshi, CEO and managing director, said: "Our performance is steadily strengthening, reflecting disciplined execution and a focused strategy. Deal wins have increased by 44% on a last twelve months (LTM) basis, supported by broad-based momentum across verticals and geographies." Rohit Anand, chief financial officer, said, 'We have delivered seven consecutive quarters of margin expansion - a clear reflection of the discipline and focus across our organisation. Even in an uncertain environment, our Project Fortius program continues to generate meaningful results and drive operational improvements." AI-related services to lead revenue growth Tech Mahindra has forged key partnerships and is focussing on AI, which should drive growth going forward. It announced a partnership with Nuix, a global leader in AI-powered investigative analytics and intelligence software to provide innovative, scalable solutions for cyber and fraud detection. The partnership will leverage TechM's extensive expertise in AI, digital engineering and cyber risk management to integrate Nuix's advanced investigative and data analytics solutions into its services, unlocking significant global sales opportunities with the Nuix Neo Solutions. Tech Mahindra and KOGO AI, a category-defining provider of agentic AI infrastructure, announced a strategic collaboration to jointly build and deliver next-gen enterprise AI solutions and agents designed for autonomy, scale and compliance. Did the results disappoint? There were no major disappointments, but the 1% decline in constant-currency revenue was a negative. Weakness in the Americas and in key verticals were other areas of concern. Strong profit growth, deal wins and steady margin were the big positives. Some investors expect Tech Mahindra to start its growth trajectory next quarter based on deal ramp-ups. They anticipate that FY26 revenue growth will outpace FY25's, supported by a strong pipeline and large deal execution. Should investors worry? Some of the issues facing the company are industry-specific and not company-specific. Investors worry that though spending on AI-related infrastructure such as data centers is surging, software and IT services growth rates are expected to slow as businesses delay purchase decisions and reduce discretionary IT budgets. For Tech Mahindra specifically, margin expansion this quarter was seen as a positive. Solid growth in profits and strong deal wins were the other big highlights. However, investors remain wary about revenue growth challenges in certain verticals and the Americas. If IT spending by companies remains weak, particularly in the US and Europe, most Indian IT companies will face a challenging year. As always, you should carefully evaluate a company's fundamentals, corporate governance and valuation before making an investment decision. Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. This article is syndicated from
News.com.au
16-07-2025
- Business
- News.com.au
Closing Bell: ASX rolls back yesterday's gains as info tech stages recovery
ASX beats hasty retreat from new record high, down 0.79pc Info tech rises against the tide, adding 0.85pc Banks and financial stocks struggle alongside materials sector, leading losses Info tech fires up despite dour market The ASX unwound all its progress from yesterday, ending the day down 0.79% with nine sectors falling. It was again responding to chaos in US markets. US CPI came in hotter than desired, putting a damper on a potential rate cut from the Fed Reserve. US markets were also shaken by Treasury secretary Scott Bessent announcing the White House had initiated a formal process to remove Fed chair Jerome Powell before his term expires next year. Adding to the mix, Trump threw around some fresh rhetoric about pharmaceutical and semiconductor tariffs, but as usual we'll have to wait and see what comes of that. In the meantime, the financial sector led losses, shedding 1.36% alongside a depleted materials sector. The info tech sector staged a strong recovery though, rising 0.85% after falling 0.35% in the first half hour of trade. It was the only index to climb, adding 0.64%. Tech stocks were one of the few silver linings in an otherwise difficult day of trading. Payment management company Tyro (ASX:TYR) shot up 7.2%, analytics and intelligence firm Nuix (ASX:NXL) added 7.5%, SaaS software provider Infomedia (ASX:IFM) climbed 4.4% and big cap Megaport (ASX:MP1) added 6.2%. Banks sold down as market struggles One of the bigger victims of today's sell down was the seven major banking stocks. Their index plunged 1.6%. National Australian Bank (ASX:NAB) has been under fire in recent days, as major shareholders raise concerns about chief executive Andrew Irvine's management style and lifestyle choices. Not surprising then that NAB led banking losses, down 3.18%. Retail investor favourite Commonwealth Bank (ASX:CBA) slid 1.2%, ANZ Group (ASX:ANZ) 0.79%, Westpac (ASX:WBC) 1.57%, Macquarie (ASX:MQG) 0.77%, QBE (ASX:QBE) 1% and Suncorp (ASX:SUN) 0.49%. ASX SMALL CAP LEADERS Today's best performing small cap stocks: Code Name Last % Change Volume Market Cap MIOR Macarthur Minerals 0.003 200% 447404 $99,833 FTC Fintech Chain Ltd 0.004 100% 1592539 $1,301,539 KNG Kingsland Minerals 0.145 53% 290323 $6,893,287 ERL Empire Resources 0.006 50% 1546439 $5,935,653 EEL Enrg Elements Ltd 0.002 33% 1912486 $4,880,668 AKN Auking Mining Ltd 0.006 33% 37340109 $3,096,523 PV1 Provaris Energy Ltd 0.017 31% 4193417 $10,101,617 OEQ Orion Equities 0.195 30% 28466 $2,347,384 AX8 Accelerate Resources 0.009 29% 2097369 $5,720,321 CPM Cooper Metals Ltd 0.048 26% 294686 $2,977,515 PR1 Pure Resources Limited 0.125 25% 440609 $4,600,879 ASN Anson Resources Ltd 0.09 25% 14901420 $99,845,031 CUL Cullen Resources 0.005 25% 250433 $2,773,607 MEG Megado Minerals Ltd 0.04 25% 1909655 $20,661,864 PIL Peppermint Inv Ltd 0.0025 25% 343838 $4,602,180 PPG Pro-Pac Packaging 0.02 25% 352939 $2,907,003 PPY Papyrus Australia 0.01 25% 136062 $4,581,454 RLG Roolife Group Ltd 0.005 25% 2019881 $6,371,125 LKY Locksley Resources 0.115 24% 26061959 $17,050,000 CP8 Canphosphateltd 0.074 23% 187789 $18,405,632 SNS Sensen Networks Ltd 0.037 23% 20027 $23,791,124 IBX Imagion Biosys Ltd 0.017 21% 27940131 $2,818,780 RPG Raptis Group Limited 0.12 20% 140947 $35,068,485 AYT Austin Metals Ltd 0.003 20% 181536 $3,960,478 BNL Blue Star Helium Ltd 0.006 20% 145568 $13,474,426 Making news... Lumos Diagnostics (ASX:LDX) has cleared a path to enter US markets, inking a six-year exclusive deal for the distribution of FebriDx with PHASE Scientific, valued at up to US$317 million. There are still some hurdles to clear – the company will need to secure a CLIA waiver classification from the FDA – but LDX has already enrolled 105 of 120 patients in its CLIA study and expects to have the paperwork in hand within the next three months. Noxopharm (ASX:NOX) has administered the first dose of SOF-SKN in its HERACLES trial, a first-in-human study evaluating SOF-SKN as a novel drug candidate for autoimmune diseases. Currently at the safety and tolerability stage of clinical testing, NOX will dose four cohorts of four patients each in progressively higher dosages, with the goal of targeting the US$3 billion lupus market. Catalina Resources (ASX:CTN) is chasing up a stellar rare earth drill hit at the Laverton project that closely mirrors mineralisation found at the nearby Mt Weld mine (ASX:LYC), one of the most valuable rare earth deposits in the world. On top of following up on the 9m at 7565 parts per million total rare earth oxide result, CTN is also exploring for gold in the Barnicoat Shear Zone at Laverton, host to several existing gold deposits. Javelin Minerals (ASX:JAV) has lifted the grade and confidence levels of its Eureka gold project resource estimate, increasing the overall resource grade 16% to 1.69 g/t gold for 110,687 ounces. The update also added more tonnes to the indicated category, lifting it to 1.36Mt at 1.8 g/t gold for 78,678 ounces, a 27% increase. ASX SMALL CAP LAGGARDS Today's worst performing small cap stocks: Code Name Last % Change Volume Market Cap AOA Ausmon Resorces 0.001 -50% 1226988 $2,622,427 SFG Seafarms Group Ltd 0.001 -50% 6000 $9,673,198 SKN Skin Elements Ltd 0.002 -33% 55557 $3,225,642 CTN Catalina Resources 0.003 -25% 1743751 $9,704,076 FAU First Au Ltd 0.003 -25% 16503 $8,305,165 GTR Gti Energy Ltd 0.003 -25% 3176612 $14,835,762 BCB Bowen Coal Limited 0.075 -25% 2076944 $10,775,756 APC APC Minerals 0.008 -24% 10585499 $3,075,800 X2M X2M Connect Limited 0.014 -22% 1532537 $7,831,023 AMS Atomos 0.004 -20% 55022 $6,075,092 M2R Miramar 0.004 -20% 13877015 $4,984,116 MRD Mount Ridley Mines 0.002 -20% 3700 $1,946,223 PRM Prominence Energy 0.002 -20% 891688 $1,216,176 RNX Renegade Exploration 0.004 -20% 150000 $6,441,817 SLZ Sultan Resources Ltd 0.004 -20% 639757 $1,157,350 SPQ Superior Resources 0.004 -20% 2402254 $11,854,914 RDG Res Dev Group Ltd 0.009 -18% 68225 $32,459,439 THB Thunderbird Resource 0.009 -18% 2384348 $4,287,156 RMI Resource Mining Corp 0.014 -18% 2369600 $12,485,707 ARV Artemis Resources 0.005 -17% 1637579 $15,214,033 AZL Arizona Lithium Ltd 0.005 -17% 18139597 $31,621,887 CC9 Chariot Corporation 0.059 -16% 525881 $8,354,764 AJL AJ Lucas Group 0.006 -14% 156934 $9,630,107 BLU Blue Energy Limited 0.006 -14% 20000 $12,956,815 BYH Bryah Resources Ltd 0.006 -14% 3574 $6,789,675 IN CASE YOU MISSED IT The Hong Kong Electrical and Mechanical Services Department has produced a glowing report on a trial installation of ClearVue Technologies (ASX:CPV) solar façade products, sketching out a payback period of less than 3 years. Trigg Minerals (ASX:TMG) has locked in the Bernhardt Group to lead engagement with US officials at Antimony Canyon. Bryah Resources (ASX:BYH) has highlighted the antimony potential of the Golden Pike gold project in New Brunswick, Canada, during a due diligence review. Prescient Therapeutics (ASX:PTX) initiates first US site for the Phase 2a trial of PTX-100 in patients with relapsed/refractory Cutaneous T-Cell Lymphoma. European Lithium (ASX:EUR) has applauded Critical Metals Corp's drilling at the Tanbreez rare earth project in Greenland. Tryptamine Therapeutics (ASX:TYP) has bolstered its clinical development team with two key appointments as it progresses lead drug candidate IV-infused psilocin TRP-8803. Pure Hydrogen Corporation (ASX:PH2) has sold its first hydrogen-powered truck to Riverview International Trucks in California. Axel REE (ASX:AXL) says assays from auger drilling at its Caladão project in Brazil have delivered strong gallium and rare earths results. TRADING HALTS At Stockhead, we tell it like it is. While Lumos Diagnostics and Javelin Minerals are Stockhead advertisers, they did not sponsor this article.
Yahoo
16-06-2025
- Business
- Yahoo
3 Undervalued Small Caps In Asian Markets With Insider Buying
Amidst escalating geopolitical tensions and fluctuating trade dynamics, Asian markets have been navigating a complex landscape, with key indices reflecting mixed performances. As investors seek opportunities in this environment, small-cap stocks with insider buying can offer intriguing prospects due to their potential for growth and resilience in uncertain times. Name PE PS Discount to Fair Value Value Rating Security Bank 4.2x 1.0x 40.47% ★★★★★★ East West Banking 3.0x 0.7x 35.89% ★★★★★☆ Lion Rock Group 5.0x 0.4x 49.95% ★★★★☆☆ Dicker Data 18.0x 0.6x -10.93% ★★★★☆☆ Atturra 26.9x 1.1x 36.52% ★★★★☆☆ Sing Investments & Finance 7.4x 3.7x 38.61% ★★★★☆☆ Select Harvests 19.4x 1.7x -48.39% ★★★★☆☆ PWR Holdings 33.9x 4.7x 25.11% ★★★☆☆☆ Charter Hall Long WALE REIT NA 12.5x 20.22% ★★★☆☆☆ AInnovation Technology Group NA 2.4x 46.49% ★★★☆☆☆ Click here to see the full list of 61 stocks from our Undervalued Asian Small Caps With Insider Buying screener. Here's a peek at a few of the choices from the screener. Simply Wall St Value Rating: ★★★★☆☆ Overview: Nuix is a technology company specializing in software and programming solutions, with a focus on data analytics and cybersecurity, and has a market capitalization of A$0.43 billion. Operations: Nuix generates revenue primarily from its Software & Programming segment, with recent figures reaching A$227.37 million. The company's gross profit margin has shown a trend of staying around 90% in recent periods, indicating a strong ability to manage costs relative to sales. Operating expenses are significant, driven by Sales & Marketing and R&D expenditures, which together account for a substantial portion of costs. Despite fluctuations in net income margins, the company has experienced both losses and modest profits over various periods. PE: -1369.0x Nuix, recently added to the S&P/ASX 200 Index in March 2025, operates with a funding structure reliant solely on external borrowing, which carries inherent risks. However, insider confidence is evident through recent share purchases over the past year. The company projects significant earnings growth at nearly 54% annually. As a smaller player in Asia's tech landscape, these factors suggest potential for future expansion and value realization despite its riskier financial structure. Take a closer look at Nuix's potential here in our valuation report. Examine Nuix's past performance report to understand how it has performed in the past. Simply Wall St Value Rating: ★★★★☆☆ Overview: Select Harvests is an agribusiness company primarily engaged in the cultivation, processing, and marketing of almonds, with a market capitalization of approximately A$0.61 billion. Operations: Select Harvests generates revenue primarily from its almond segment, with recent quarterly revenues reaching A$373.97 million. The company's cost structure is significantly impacted by the cost of goods sold (COGS), which was A$301.03 million in the latest quarter, leading to a gross profit margin of 19.50%. Operating expenses and non-operating expenses further affect profitability, with net income recorded at A$32.60 million for the same period and a net income margin of 8.72%. PE: 19.4x Select Harvests, a small cap in Asia, has shown promising financial performance with recent half-year sales reaching A$104.5 million, up from A$67.8 million the previous year. Net income swung to A$28.67 million from a loss of A$2.4 million, reflecting operational improvements. Insider confidence is evident with share purchases over the past year, signaling potential value recognition by those close to the company. Despite relying on external borrowing for funding, earnings are projected to grow 14% annually, suggesting room for future growth amidst current challenges. Dive into the specifics of Select Harvests here with our thorough valuation report. Review our historical performance report to gain insights into Select Harvests''s past performance. Simply Wall St Value Rating: ★★★★☆☆ Overview: ValueMax Group is involved in pawnbroking, moneylending, and the retail and trading of jewellery and gold with a market capitalization of S$0.45 billion. Operations: The company's revenue is primarily driven by the retail and trading of jewellery and gold, followed by pawnbroking and moneylending. Over recent periods, the gross profit margin has shown a notable increase, reaching 30.28% as of December 2024. Operating expenses have consistently risen alongside revenue growth, with general and administrative expenses being a significant component. PE: 6.5x ValueMax Group, a small company in Asia, has captured attention with insider confidence shown through recent share purchases. Despite relying on external borrowing for funding, its financial position remains solid as operating cash flow adequately covers debt. In April 2025, they launched a new commercial paper series aiming to raise up to SG$25 million at 3.9% interest annually. The company also declared a final dividend of 2.68 cents per share for the year ending December 2024, reflecting potential future growth and investor appeal. Delve into the full analysis valuation report here for a deeper understanding of ValueMax Group. Evaluate ValueMax Group's historical performance by accessing our past performance report. Click through to start exploring the rest of the 58 Undervalued Asian Small Caps With Insider Buying now. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:NXL ASX:SHV and SGX:T6I. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
16-06-2025
- Business
- Yahoo
An Intrinsic Calculation For Nuix Limited (ASX:NXL) Suggests It's 45% Undervalued
The projected fair value for Nuix is AU$4.03 based on 2 Stage Free Cash Flow to Equity Nuix is estimated to be 45% undervalued based on current share price of AU$2.23 The AU$4.40 analyst price target for NXL is 9.1% more than our estimate of fair value How far off is Nuix Limited (ASX:NXL) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the forecast future cash flows of the company and discounting them back to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex. Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (A$, Millions) AU$9.45m AU$39.7m AU$51.3m AU$60.2m AU$68.1m AU$74.9m AU$80.8m AU$86.0m AU$90.6m AU$94.9m Growth Rate Estimate Source Analyst x2 Analyst x2 Analyst x2 Est @ 17.39% Est @ 13.06% Est @ 10.03% Est @ 7.90% Est @ 6.42% Est @ 5.38% Est @ 4.65% Present Value (A$, Millions) Discounted @ 7.9% AU$8.8 AU$34.1 AU$40.9 AU$44.5 AU$46.6 AU$47.5 AU$47.5 AU$46.9 AU$45.8 AU$44.4 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = AU$407m After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.9%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 7.9%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = AU$95m× (1 + 2.9%) ÷ (7.9%– 2.9%) = AU$2.0b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= AU$2.0b÷ ( 1 + 7.9%)10= AU$926m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is AU$1.3b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of AU$2.2, the company appears quite good value at a 45% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Nuix as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.9%, which is based on a levered beta of 1.140. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. See our latest analysis for Nuix Whilst important, the DCF calculation ideally won't be the sole piece of analysis you scrutinize for a company. DCF models are not the be-all and end-all of investment valuation. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. What is the reason for the share price sitting below the intrinsic value? For Nuix, we've compiled three pertinent factors you should look at: Financial Health: Does NXL have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk. Future Earnings: How does NXL's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the ASX every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
08-04-2025
- Business
- Yahoo
Insider Buying Highlights 3 Undervalued Asian Small Caps
Amidst heightened global trade tensions and the resulting volatility in financial markets, Asian small-cap stocks have faced significant challenges, with indices reflecting broader market declines. Despite this turbulence, certain small-cap companies in Asia may present opportunities for investors as they exhibit resilience and potential for growth through strategic insider investments. Name PE PS Discount to Fair Value Value Rating Security Bank 4.6x 1.1x 40.67% ★★★★★★ Atturra 24.8x 1.0x 45.34% ★★★★★☆ Viva Energy Group NA 0.1x 41.33% ★★★★★☆ Puregold Price Club 8.2x 0.3x 15.09% ★★★★☆☆ Dicker Data 18.6x 0.6x -32.06% ★★★★☆☆ Sing Investments & Finance 7.0x 3.6x 44.13% ★★★★☆☆ PWR Holdings 34.2x 4.7x 26.20% ★★★☆☆☆ Zip Co NA 1.7x -29.58% ★★★☆☆☆ Integral Diagnostics 142.4x 1.6x 46.19% ★★★☆☆☆ Manawa Energy NA 2.6x 44.23% ★★★☆☆☆ Click here to see the full list of 59 stocks from our Undervalued Asian Small Caps With Insider Buying screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Value Rating: ★★★★☆☆ Overview: Nuix is a technology company specializing in software and programming solutions, with a market capitalization of A$0.38 billion. Operations: The company generates revenue primarily from its software and programming segment, with the latest reported revenue at A$227.37 million. Its gross profit margin has shown fluctuations, reaching 90.03% in the most recent period. Operating expenses are significant, with notable allocations to sales and marketing as well as research and development efforts. PE: -1544.6x Nuix, a smaller player in the tech sector, recently joined the S&P/ASX 200 Index. Despite reporting a net loss of A$10.4 million for the half-year ending December 2024, sales increased to A$105.19 million from A$98.44 million year-on-year. Insider confidence is evident with Jonathan Rubinsztein acquiring 70,000 shares worth approximately A$238,499 in March 2025. Although reliant on external borrowing for funding, Nuix forecasts earnings growth of over 53% annually, suggesting potential for future value creation amidst its challenges. Dive into the specifics of Nuix here with our thorough valuation report. Gain insights into Nuix's historical performance by reviewing our past performance report. Simply Wall St Value Rating: ★★★★★★ Overview: Perpetual is a diversified financial services company focusing on asset management and wealth management, with operations generating revenue primarily from these segments and a market capitalization of A$1.83 billion. Operations: Revenue primarily stems from Asset Management and Wealth Management, with a significant portion allocated to operating expenses. The gross profit margin has shown a decreasing trend, reaching 39.09% by the end of 2024. Net income margins have turned negative in recent periods, influenced by rising non-operating expenses and depreciation costs. PE: -3.7x Perpetual's recent performance highlights a mixed picture, with sales rising to A$693 million for the half-year ending December 2024, up from A$657.8 million in the previous year. However, net income dropped significantly to A$12 million from A$34.5 million. The company's dividend decreased to 61 cents per share for the first half of 2025. Insider confidence is evident as Christopher Mark Jones increased their shareholding by over 100% in February 2025, purchasing shares worth approximately A$159,420. Despite challenges like high-risk external borrowing and fluctuating earnings, growth prospects remain optimistic with an anticipated annual earnings increase of over 68%. Click here to discover the nuances of Perpetual with our detailed analytical valuation report. Gain insights into Perpetual's past trends and performance with our Past report. Simply Wall St Value Rating: ★★★★★☆ Overview: Viva Energy Group operates as an integrated downstream petroleum company in Australia, focusing on refining, supplying, and marketing fuels and lubricants, with a market capitalization of A$4.13 billion. Operations: The company's revenue streams are primarily driven by its Commercial & Industrial and Convenience & Mobility segments, with the former generating A$18.71 billion and the latter A$11.43 billion. Over recent periods, the gross profit margin has shown fluctuations, reaching 9.62% by December 2024 from a low of -4.61% in June 2019. The cost of goods sold (COGS) constitutes a significant portion of expenses, impacting profitability across various periods. PE: -30.8x Viva Energy Group, a smaller player in the Asian market, shows potential despite challenges. With earnings forecasted to grow 39.53% annually, there's optimism around future performance. However, their reliance on external borrowing adds risk to their financial structure. Recent reports reveal a net loss of A$76.3 million for 2024 against previous profits, and dividends have decreased to A$0.039 per share for the last half-year period ending December 2024. Insider confidence remains steady with recent share purchases indicating belief in recovery prospects amidst current hurdles. Click here and access our complete valuation analysis report to understand the dynamics of Viva Energy Group. Learn about Viva Energy Group's historical performance. Click this link to deep-dive into the 59 companies within our Undervalued Asian Small Caps With Insider Buying screener. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:NXL ASX:PPT and ASX:VEA. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
